Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-8626Fax+1 603-650-7791
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
University of Vermont Medical CenterResidency, Internal Medicine, 1986 - 1989
University of Rochester School of Medicine and DentistryClass of 1986
Certifications & Licensure
NH State Medical License 1992 - 2026
VT State Medical License 1986 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Fellow (FACP) American College of Physicians, 2002
Clinical Trials
- Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma Start of enrollment: 2000 Jan 01
- Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer Start of enrollment: 2010 Jun 01
- Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Publications & Presentations
PubMed
- 79 citationsEpidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.W. Jeffrey Petty, Konstantin H. Dragnev, Vincent A. Memoli, Yan Ma, Neil Desai
Clinical Cancer Research. 2004-11-15 - 27 citationsDocetaxel and gemcitabine combinations in non-small cell lung cancer.N. A. Rizvi, C. H. Spiridonidis, T. H. Davis, P. Bhargava, John L. Marshall
Seminars in Oncology. 1999-10-01 - 61 citationsCombination Immunotherapy of B-Cell Non-Hodgkin’s Lymphoma with Rituximab and Interleukin-2: A Preclinical and Phase I StudyCharles F. Eisenbeis, Andrew Grainger, Beth Fischer, Robert A. Baiocchi, Lester Carrodeguas
Clinical Cancer Research. 2004-09-15
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
